JCVI say children should not be COVID vaccinated.
The Joint Committee on Vaccination and Immunisation (JCVI) are advisers to the UK Government. The JCVI published a statement on 3rd September 2021 regarding COVID vaccination of children aged 12 to 15.
It relied upon the findings of 3 science studies:
A 2021 investigation of the data by Smith concluded, “SARS-CoV-2 is very rarely fatal in children and young people” and noted that “99·995% of children and young people with a positive SARS-CoV-2 test survived.”
A 2021 investigation of the data by Ward found “extremely low numbers of Children and Young People required Paediatric Intensive Care or died as a result of SARS-CoV-2 in the first pandemic year” and those with pre-existing health conditions were more likely to be hospitalised than those who are otherwise healthy.
A 2021 review of the literature by Harwood found, of the hospitalised Children and Young People, the “greatest vulnerability of severe disease or death from SARS-CoV-2 infection are those with cardiac or neurological conditions, or 2 or more comorbid conditions, and those who are obese.”
The JCVI say there is “increasingly robust evidence of an association between vaccination with mRNA COVID-19 vaccines and myocarditis” and say that the “rate of myocarditis is higher following a second dose of mRNA vaccine, compared with the first dose.” They continue by highlighting the dangers of taking an untested medical intervention by saying that “the medium and long-term (months to years) prognosis, including the possibility of persistence of tissue damage resulting from inflammation, is currently uncertain as sufficient follow-up time has not yet occurred.”
Regarding the benefit of the vaccine, the JVCI say “the margin of benefit, based primarily on a health perspective, is considered too small to support advice on a universal programme of vaccination of otherwise healthy 12 to 15-year-old children at this time.”
When weighing up the vaccine risk the JVCI say “the potential risks from vaccination are also small, with reports of post-vaccination myocarditis being very rare, but potentially serious and still in the process of being described. Given the rarity of these events and the limited follow-up time of children and young people with post-vaccination myocarditis.”
Only myocarditis, suffered by children like 17-year-old Everest Romney is actually mentioned and regarding the unknown or unrecognised serious adverse reactions, the JVCI says that “there is considerable uncertainty regarding the magnitude of the potential harms.” There are many children suffering complex adverse reactions, like 12-year-old Maddie de Garay.
The survival rate is 99.995% therefore, 99.995% of children fight the SARS-2 version of the cold virus off in exactly the same way as they have with every other common-cold they have delt with in their lives.
The facts say that no healthy child between 12 and 15 should take the vaccine, it is very clear.
References:
GOV.UK – JCVI statement on COVID-19 vaccination of children aged 12 to 15 years: 3 September 2021. Available from https://www.gov.uk/government/publications/jcvi-statement-september-2021-covid-19-vaccination-of-children-aged-12-to-15-years/jcvi-statement-on-covid-19-vaccination-of-children-aged-12-to-15-years-3-september-2021
Everest Romney – story – No More Silence. Available from https://nomoresilence.world/pfizer-biontech/everest-romney-pfizer-adverse-reaction/
Harwood, R., Yan, H., Da Camara, N.T., Smith, C., Ward, J., Tudur-Smith, C., Linney, M., Clark, M., Whittaker, E., Saatci, D. and Davis, P.J., 2021. Which children and young people are at higher risk of severe disease and death after SARS-CoV-2 infection: a systematic review and individual patient meta-analysis. medRxiv. Available from https://www.medrxiv.org/content/10.1101/2021.06.30.21259763v1?rss=1%22&utm_source=dlvr.it&utm_medium=tumblr
Maddie de Garay– story – No More Silence. Available from https://nomoresilence.world/pfizer-biontech/maddie-de-garay-pfizer-12-15-year-old-clinical-trials/
Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., Hargreaves, D., Ladhani, S., Draper, E., Davis, P. and Kenny, S., 2021. Deaths in Children and Young People in England following SARS-CoV-2 infection during the first pandemic year: a national study using linked mandatory child death reporting data. Available from https://www.medrxiv.org/content/10.1101/2021.07.07.21259779v1?utm_source=mangueijoada.com.br&utm_medium=referral&utm_content=portal_primenews&utm_campaign=hotfixpress
Ward, J., Harwood, R., Smith, C., Kenny, S.E., Clark, M., Davis, P.J., Draper, E.S., Hargreaves, D., Ladhani, S.N., Linney, M. and Luyt, K., 2021. Risk factors for intensive care admission and death amongst children and young people admitted to hospital with COVID-19 and PIMS-TS in England during the first pandemic year. medRxiv. Available from https://www.medrxiv.org/content/10.1101/2021.07.01.21259785v1